Definitive Contract 75D30120C09558
- Not listed
- This $400,185.00 definitive contract was awarded by the Centers for Disease Control and Prevention (CDC) to the Georgia Tech Research Corporation (Georgia Tech) to support COVID-19 research under the FY 2020 Broad Agency Announcement (BAA) Topic 1. The contract has a period of performance ending on June 30, 2022 and does not have a set-aside designation. As a non-profit research organization and state institution of higher learning, Georgia Tech has extensive experience conducting research and...
- This is a $345,000.00 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to the Georgia Tech Research Corporation, also known as the Office of Sponsored Programs. The contract is for FY 2020 COVID-19 Broad Agency Announcement (BAA) Topic 1 research and was awarded on March 15, 2021, with a completion date of June 30, 2023. Georgia Tech Research Corporation is a non-profit research organization and state institution of higher education associated with the...
- This is a $274,822.00 firm-fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to the Georgia Tech Research Corporation, also known as the Office of Sponsored Programs, on July 1, 2021. The contract supports FY 2020 COVID-19 Broad Agency Announcement (BAA) Topic 2 and has an ultimate completion date of April 29, 2022. Georgia Tech Research Corporation is a non-profit research organization and state institution of higher education associated with the...
- This is a federal contract award to the Georgia TECH Research Corporation, doing business as the Office of Sponsored Programs, with a ceiling value of $95,035. The contract was awarded by the Centers for Disease Control and Prevention (CDC) on September 30, 2020 and is in support of the FY 2020 COVID-19 TOPIC 2 - GA TECH effort. The contract does not have a set-aside designation. Georgia TECH Research Corporation is a non-profit research organization and state institution of higher education...
- This firm fixed price purchase order was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Georgia Tech Research Corporation (Georgia Tech) for $300,000.00 to provide mathematical modeling in support of the COVID-19 response. The contract period of performance is from May 10, 2021 to April 25, 2022. This award does not have a small business set-aside designation. Georgia Tech, a non-profit research organization and state institution of...
- The Centers for Disease Control and Prevention (CDC) Atlanta awarded a $145.8K firm fixed-price purchase order to Georgia Tech Research Corporation to characterize pathogen-specific antibody responses related to COVID-19. The award, issued on August 25, 2021, carries an ultimate completion date of August 31, 2025, with performance taking place in Atlanta, Georgia. No set-aside designation was applied to this contract, indicating open competition. Georgia Tech Research Corporation, operating...
- This is a definitive contract awarded by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to Georgia Institute of Technology Research Corporation (Georgia Tech Research Corp), doing business as the Office of Sponsored Programs. The contract, awarded on September 22, 2017, has a potential value of $301,682.00 and a completion date of March 31, 2019. The contract is not designated as a set-aside. Georgia Tech Research Corp is a non-profit...
- This $85,000.00 firm-fixed-price purchase order contract was awarded by the Centers for Disease Control and Prevention (CDC) to the Georgia Tech Research Corporation (Georgia Tech), a non-profit research organization and state institution of higher education. The contract is for the development of a bioinformatics tool, and does not have a set-aside designation. Georgia Tech has a significant track record of securing federal contracts and grants across a wide range of technical domains, often...
- This firm fixed-price purchase order was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to the Georgia Tech Research Corporation, a non-profit organization and state-controlled institution of higher education. The $133,000 contract is for the development of monoclonal antibodies and immunoassays to spike variants, in support of the national response to the Coronavirus (COVID-19) pandemic. Georgia Tech Research Corporation has extensive...
- This is a $150,000 firm fixed-price purchase order contract awarded by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to Georgia Tech Research Corporation, doing business as the Office of Sponsored Programs. The contract is for technical services and does not have a set-aside designation. Georgia Tech Research Corporation is a non-profit research organization and state institution of higher education that provides a range of research,...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $599,899.12 definitive contract to the Georgia Tech Research Corporation (Georgia Tech) to support COVID-19 research under the FY 2020 COVID-19 Broad Agency Announcement (BAA) Topic 3.1. The contract, which does not have a set-aside designation, is for a project titled "FY 2020 COVID-19 BAA TOPIC 3.1 GA TECH" with a period of performance through September 29, 2022. As a non-profit research organization and state institution of higher education, Georgia Tech has extensive experience conducting research and providing technical services to federal agencies, including the Department of Defense, Department of Energy, NASA, NSF, and NIH. The award builds on Georgia Tech's ongoing work to support the government's pandemic response efforts through advanced scientific and technological solutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Terminate for Convenience | ($326k) | 8/26/22 | |
| P00001 | Other Administrative Action | $0 | 12/14/21 | |
| Not listed | Not listed | $926.1k | 8/20/20 |